SRAX, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2022
Full-year 2022 guidance of $46 million - $48 million, an increase of 46% - 52% over 2021 unaudited revenue of approximately $31.5 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 USD | -27.46% |
|
+2,743.14% | +850.82% |
05-08 | DNA Holdings LLC entered into a definitive merger agreement to acquire remaining 65% stake in SRAX, Inc.. | CI |
04-02 | SRAX, Inc. announced that it has received $0.075 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+850.82% | 8.45M | |
+18.31% | 26.64B | |
+3.69% | 17.57B | |
-4.11% | 12.04B | |
-10.88% | 10.98B | |
-3.80% | 9.82B | |
+0.93% | 4.19B | |
-2.17% | 3.32B | |
+13.83% | 3.17B | |
-28.56% | 3.04B |